MLICM
IMGO

Metropolitan Life Insurance Company (MetLife)’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,707
Closed -$61.4K – 2531
2022
Q4 		$61.4K Buy
1,707
+234
+16% +$5.85K ﹤0.01% 1344
2022
Q3 		$22.2K Hold
1,473
– – ﹤0.01% 1976
2022
Q2 		$19.7K Hold
1,473
– – ﹤0.01% 2060
2022
Q1 		$28.4K Buy
+1,473
New +$30.6K ﹤0.01% 1921

Metropolitan Life Insurance Company (MetLife)'s IMGO Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 1,707 shares — an estimated $61.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $61.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,707 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $61.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Imago BioSciences, Inc. Common stock position peaked at $61.4K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.